Adia Med Inc (ADIA) Fair Value 2026

ADIA · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.2 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-27, Adia Med Inc (ADIA) trades at $0.15. QOC: 5.2/10. Value Trap Risk: 0/100 (SAFE). 0/13 models active.

Key Facts

Ticker
ADIA
Price
$0.15
Quality Score
5.2/10
Value Trap Risk
0/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give ADIA?

0 Intrinsic Value Models vs. Current Price ($0.15)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Adia Med Inc (ADIA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Adia Med Inc currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About ADIA?

0 of 13 models are currently active for ADIA. See which stocks rank higher →

How Does ADIA Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, ADIA ranks #48 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

Adia Med Inc operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ADIA a Value Trap?

CirclFi's Value Trap algorithm assigns ADIA a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Adia Med Inc. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Adia Med Inc's fundamental quality profile registers 5.2/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ADIA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Adia Med Inc Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

WWWW International, Inc.QOC 5.5SNDASonida Senior Living, Inc.QOC 5.2ACHCAcadia Healthcare Company, Inc.QOC 5.6BICXBioCorRx Inc.QOC 4.9STLNThe Oncology Institute, Inc.QOC 5.6BMGLBasel Medical Group LtdQOC 4.8EHCEncompass Health CorporationQOC 8.7GRDNGuardian Pharmacy Services, Inc.QOC 7.6SGRYSurgery Partners, Inc.QOC 6.4ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: WW · SNDA · ACHC · BICX · STLN · BMGL · EHC · GRDN · SGRY · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to ADIA?

7 companies across all industries closest to ADIA’s Quality of Company score of 5.2/10.

LSEBLSEB Creative Corp.QOC 5.2INVZInnoviz Technologies Ltd.QOC 5.2CNNECannae Holdings, Inc.QOC 5.2AVIRAtea Pharmaceuticals, Inc.QOC 5.2CISOCISO Global Inc.QOC 5.2CMTGClaros Mortgage Trust, Inc.QOC 5.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LSEB · INVZ · CNNE · AVIR · CISO · CMTG · NVDA

Where Does ADIA Sit in CirclFi's Medical Care Facilities Rankings?

ADIA is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About Adia Med Inc’s Valuation?

What is Adia Med Inc's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Adia Med Inc (ADIA). The Quality of Company score is 5.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ADIA overvalued or undervalued right now?

At $0.15, 0 of 0 active models suggest ADIA may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Adia Med Inc's business model in Medical Care Facilities.

What does a Quality of Company score of 5.2 mean for ADIA?

Adia Med Inc's QOC of 5.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ADIA?

CirclFi analyzes ADIA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is ADIA a value trap in 2026?

Adia Med Inc's Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Adia Med Inc (ADIA) a Quality of Company score of 5.2/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/ADIA/ · Methodology
Primary sources for this ADIA valuation
  • Financial statements: Adia Med Inc 10-K and 10-Q filings on SEC EDGAR (CIK 0001160420) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ADIA as of ; valuations recomputed .